You are here: Industry Insights > disorder

News List

A new drug could revolutionize the treatment of neurological disorders worldpharmanews
August 29, 2019
The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may prevent neuronal death...
Exposure to Pollution May Up Risk for Psychiatric Disorders drugs
August 21, 2019
Environmental pollution appears to be associated with an increased risk for psychiatric disorders, especially bipolar disorder and major depression, according to a report published online in PLOS Biology.
'No Quick Fix' for A-Fib, But Cardiologist Says You Can Help Prevent It drugs
August 20, 2019
There is no cure for a-fib, but the common heart disorder can be managed, an expert says.Atrial fibrillation -- which can lead to blood clots, stroke, heart failure and other heart-related complications...
Depression Symptoms Greater in Mothers With Prior Eating Disorders drugs
June 14, 2019
Depression Symptoms Greater in Mothers With Prior Eating Disorders.
Stepped Tx for Alcohol Use Disorder Studied in HIV Patients drugs
May 31, 2019
Stepped Tx for Alcohol Use Disorder Studied in HIV Patients.
Transgender No Longer Classified as Mental Health Disorder by WHO drugs
May 30, 2019
Transgender people will no longer be classified as having a mental disorder by the World Health Organization.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 08, 2019
Researchers define Alzheimer's-like brain disorder.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 07, 2019
A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition.
Acquisition of Marketing Approval for VYVANSE Capsule 20mg/30mg for Treatment of Attention Deficit Hyperactivity Disorder firstwordpharma
April 14, 2019
Shionogi will establish a strict distribution management system based on the approval conditions and make a positive contribution to therapy for patients who need VYVANSE®.
Resmed dominates the niche sleep disorder market biospectrumasia
October 23, 2018
A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorde

Previous page 1 2 Next page